Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy.
A better understanding of changes in HIV-1 population genetics with combination antiretroviral therapy (cART) is critical for designing eradication strategies. We therefore analyzed HIV-1 genetic variation and divergence in patients' plasma before cART, during suppression on cART, and after vir...
Guardado en:
Autores principales: | Mary F Kearney, Jonathan Spindler, Wei Shao, Sloane Yu, Elizabeth M Anderson, Angeline O'Shea, Catherine Rehm, Carry Poethke, Nicholas Kovacs, John W Mellors, John M Coffin, Frank Maldarelli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e79a5c84d0242e3801880d4e7d8f9e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule.
por: Lina Josefsson, et al.
Publicado: (2013) -
Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations
por: Yuta Hikichi, et al.
Publicado: (2021) -
Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.
por: Datsen George Wei, et al.
Publicado: (2014) -
Temporal analysis of image-rivalry suppression.
por: Rishi Bhardwaj, et al.
Publicado: (2012) -
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.
por: Rajesh T Gandhi, et al.
Publicado: (2010)